Voluntary disclosure of the announcement that the company was selected as the sixth batch of specialized, special and new “little giant” enterprises at the national level
SDIC Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shenzhen Microchip Biotechnology Co., Ltd.
Investor Relations Activity Record Form 2024 8/29
Voluntary Disclosure Notice Regarding Acceptance of Clinical Trial Applications for the Treatment of Extensive Small Cell Lung Cancer with Theoroni Capsules
Investor Relations Activity Record Form August 21, 2024
Investor relations event record for August 16th, 2024.
Investor Relations Activity Record for August 19, 2024
Special report on the storage and use of funds raised in the first half of 2024.
Announcement of the resolution of the fourth meeting of the third board of supervisors.
Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.
Half-year report for the year 2024.
Announcement of the resolution of the fifth meeting of the third board of directors.
Summary of Half-Year Report in 2024.
Announcement regarding the holding of a mid-year 2024 performance briefing and the 2024 Investor Open Day event.
Guotou Securities Co., Ltd.'s verification opinion regarding the use of temporarily idle raised funds by Shenzhen Chipscreen Biosciences Co., Ltd. for cash management.
Announcement regarding the use of temporarily idle raised funds for cash management.
Voluntary disclosure announcement regarding the approval of clinical trial notification for the treatment of colorectal cancer with Xidabenamine.
Voluntary disclosure of the announcement regarding the approval of the indications for the use of empagliflozin and metformin hydrochloride in the treatment of type 2 diabetes.
Announcement on the results of convertible bonds and changes in shareholding
Announcement regarding the interest payment for Weichip Convertible Bonds in 2024.
No Data